-
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Source: Buzz FX / 24 Nov 2024 01:26:10 America/Chicago
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Given Consensus Recommendation of "Moderate Buy" by Brokerages Written by MarketBeat November 24, 2024 Share Link copied to clipboard. Shares of Halozyme Therapeutics, Inc.
Read more...